References

  1. Cartot A, Pineton De Chambrun G, Vernier-Massouille G, Vigneron B, Gower Rousseau C. Maladies inflammatoires chroniques de l’intestin, maladies génétiques ou de l’environnement? Gastroenterologie Clinique et Biologique. 2009; 33: 681-91. Google Scholar

  2. Orholm M, Munkholm P, Langholz E, Nielsen OH, Sorensen Thorkild I, Binder V. Familial occurrence of inflammatory bowel disease. N Engl J Med. 1991 Jan 10; 324(2): 84-8. PubMed | Google Scholar

  3. Tysk C, Lindberg E, Jarnerot G, Floderus-Myrhed B. Ulcerative colitis and Crohn’s disease in an unselected population of monozygotic and dizygotic twins: a study of heritability and the influence of smoking. Gut. 1988 Jul; 29(7): 990-996. PubMed | Google Scholar

  4. Sendid B, Quintom JF, Charrier G, Goulet O, Cortot A, Grandbastien B, Poulain D, Colombel JF. Anti saccharomyces cerevisiae mannan antibodies in familial Crohn’s disease. Am J Gastroenterol. 1998; 93 (8): 1306-10. PubMed | Google Scholar

  5. Hugot JP, Chamaillard M, Zouali H, Lesage S, Cézard JP, Belaich J, Almer S, Tysk C, O’Morain CA, Gassull M, Binder V, Finkel Y, Cortot A, Modiagliani R, Laurant-Puig P, Gower-Rousseau C, Macry J, Colombel JF, Sahbatou M, Thomas G. Association of NOD2 Leucine-rich repeat variants with susceptibility of Crohn’s Disease. Nature. 2001; 411: 599-603. PubMed | Google Scholar

  6. Ogura Y, Bonen DK, Inohara N, Nicolae DL, Chen FF, Ramos R, Britton H, Moran T, Karaliuskas R, Duerr RH, Achkar JP, Brant SR, Bayless TM, Kirschner BS, Hanauer SB, Nunez G, Cho JH. A frameshift mutation in NOD2 associated with susceptibility of Crohn disease. Nature. 2001; 411 (6837): 603-6. PubMed | Google Scholar

  7. Lesage S, Zouali H, Cezard JP, Colombel JF, Belaiche J, Almer S, Tysk C, O’Morain C, Gassull M, Binder V, Finkel Y, Modigliani R, Gower-Rousseau C, Macry J, Merlin F, Chamaillard M, Jannot AS, Thomas G, Hugot JP; EPWG-IBD Group; EPIMAD Group; GETAID Group. CARD15/NOD2 mutational analysis and genotype-phenotype correlation in 612 patients with inflammatory bowel disease. Am J Hum Genet. 2002; 70(4): 845-5. PubMed | Google Scholar

  8. Loftus EV Jr. Clinical epidemiology of inflammatory bowel disease: Incidence, prevalence, and environmental influences. Gastroenterology. 2004; 126 (6): 1504-17. PubMed | Google Scholar

  9. Podolsky DK. Inflammatory Bowel Disease. N Engl J Med. 2002; 347(6): 417-2. PubMed | Google Scholar

  10. Sartor RB. Microbial influences in inflammatory bowel diseases. Gastroenterology. 2008 Feb; 134(2): 577-94. PubMed | Google Scholar

  11. Calkins BM. A meta-analysis of the role of smoking in inflammatory bowel disease. Dig Dis Sci. 1989 Dec; 34(12): 1841-54. PubMed | Google Scholar

  12. Andersson RE, Olaison G, Tysk C, Ekbom A. Appendectomy and protection against ulcerative colitis. N Engl J Med. 2001 Mar 15; 344(11): 808-14. PubMed | Google Scholar

  13. Hugot JP, Laurent-Puig P, Gower-Rousseau C, Olson JM, Lee JC, Beaugerie L, Naom I, Dupas JL, Van Gossum A, Orholm M, Bonaiti-Pellie C, Weissenbach J, Mathew CG, Lennard-Jones JE, Cortot A, Colombel JF, Thomas G. Mapping of a susceptibility locus for Crohn’s disease on chromosome 16. Nature. 1996; 379 (6568): 821-3. PubMed | Google Scholar

  14. Hampe J, Cuthbert A, Croucher PJ, Mirza MM, Mascheretti S, Fisher S, Frenzel H, King K, Hasselmeyer A, MacPherson AJ, Bridger S, van Deventer S, Forbes A, Nikolaus S, Lennard-Jones JE, Foelsch UR, Krawczak M, Lewis C, Schreiber S, Mathew CG. Association between insertion mutation in NOD2 gene and Crohn’s disease in German and British populations. Lancet. 2001; 357 (9272): 1925-8. PubMed | Google Scholar

  15. Lamoril J, Deybach JC, Bouizegarène P. Maladie de Crohn et génétique: connaissances actuelles. Immuno-Analyse et Biologie Spécialisée. 2007; 22(3): 137-150. Google Scholar

  16. Cavanaugh J. NOD2: ethnic and geographic differences. World J Gastroenterol. 2006 Jun 21; 12(23): 3673-7. PubMed | Google Scholar

  17. Gaya DR, Russell RK, Nimmo ER, Satsangi J. New genes in inflammatory bowel disease: lessons for complex diseases. Lancet. 2006 Apr 15; 367(9518): 1271-84. PubMed | Google Scholar

  18. Economou M, Trikalinos TA, Loizou KT, Tsianos EV, Ioannidis JP. Differential effects of NOD2 variants on Crohn’s disease risk and phenotype in diverse populations: a metaanalysis. Am J Gastroenterol. 2004 Dec; 99(12): 2393-404. PubMed | Google Scholar

  19. Vermeire S. Review article: genetic susceptibility and application of genetic testing in clinical management of inflammatory bowel disease. Aliment Pharmacol Ther. 2006; 24(Suppl3): 2-10. PubMed | Google Scholar

  20. Van Der Linde K, Boor PP, Houwing-Duistermaat JJ, Crusius BJ, Wilson PJ, Kuipers EJ, De Rooij FW. CARD15 mutations in Dutch familial and sporadic inflammatory bowel disease and an overview of European studies. European Journal of Gastroenterology & Hepatology. 2007; 19(6): 449-59. PubMed | Google Scholar

  21. Hampe J, Grebe J, Nikolaus S, Solberg C, Croucher PJ, Mascheretti S, Jahnsen J, Moum B, Klump B, Krawczak M, Mirza MM, Foelsch UR, Vatn M, Schreiber S. Association of NOD2 (CARD 15) genotype with clinical course of Crohn's disease: a cohort study. Lancet. 2002; 359(9318): 1661-5. PubMed | Google Scholar

  22. Cavanaugh JA, Adams KE, Quak EJ, Bryce ME, O'Callaghan NJ, Rodgers HJ, Magarry GR, Butler WJ, Eaden JA, Roberts-Thomson IC, Pavli P, Wilson SR, Callen DF. CARD15/NOD2 risk alleles in the development of Crohn's disease in the Australian population. Ann Hum Genet. 2003; 67(Pt 1): 35-41. PubMed | Google Scholar

  23. Sugimura K, Taylor KD, Lin YC, Hang T, Wang D, Tang YM, Fischel-Ghodsian N, Targan SR, Rotter JI, Yang H. A novel NOD2/CARD15 haplotype conferring risk for Crohn disease in Ashkenazi Jews. Am J Hum Genet. 2003; 72(3): 509-18. PubMed | Google Scholar

  24. Arnott I.D, Nimmo ER, Drummond HE, Fennell J, Smith BR, MacKinlay E, Morecroft J, Anderson N, Kelleher D, O'Sullivan M, McManus R, Satsangi J. NOD2/CARD15, TLR4 and CD14 mutations in Scottish and Irish Crohn's disease patients: evidence for genetic heterogeneity within Europe? Genes Immun. 2004; 5(5): 417-25. PubMed | Google Scholar

  25. Annese V, Lombardi G, Perri F, D'Incà R, Ardizzone S, Riegler G, Giaccari S, Vecchi M, Castiglione F, Gionchetti P, Cocchiara E, Vigneri S, Latiano A, Palmieri O, Andriulli A. Variants of CARD15 are associated with an aggressive clinical course of Crohn's disease--an IG-IBD study. Am J Gastroenterol. 2005; 100(1): 84-92. PubMed | Google Scholar

  26. Rüegg C, Hersberger M, Wusk B, Rentsch K, Kullak-Ublick GA, von Eckardstein A, Maly FE. Detection of the Arg702Trp, Gly908Arg and Leu1007fsinsC polymorphisms of the NOD2/CARD15 gene by real-time PCR with melting curve analysis. Clin Chem Lab Med. 2004; 42(5): 494-8. PubMed | Google Scholar

  27. Vind I, Vieira A, Hougs L, Tavares L, Riis L, Andersen PS, Locht H, Freitas J, Monteiro E, Christensen IJ, Munkholm P. NOD2/CARD15 gene polymorphisms in Crohn's disease: a genotype-phenotype analysis in Danish and Portuguese patients and controls. Digestion. 2005; 72 (2-3): 156-63. PubMed | Google Scholar

  28. Büning C, Molnar T, Nagy F, Lonovics J, Weltrich R, Bochow B, Genschel J, Schmidt H, Lochs H. NOD2/CARD15 gene polymorphism in patients with inflammatory bowel disease: is Hungary different? World J Gastroenterol. 2005; 11(3): 407-11. Google Scholar

  29. Büning C, Genschel J, Bühner S, Krüger S, Kling K, Dignass A, Baier P, Bochow B, Ockenga J, Schmidt HH, Lochs H. Mutations in the NOD2/CARD15 gene in Crohn's disease are associated with ileocecal resection and are a risk factor for reoperation. Aliment Pharmacol Ther. 2004; 19(10): 1073-8. PubMed | Google Scholar

  30. Heliö T, Halme L, Lappalainen M, Fodstad H, Paavola-Sakki P, Turunen U Färkkilä M, Krusius T, Kontula K. CARD15/NOD2 gene variants are associated with familially occurring and complicated forms of Crohn's disease. Gut. 2003; 52(4): 558-62. PubMed | Google Scholar

  31. Esters N, Pierik M, Van Steen K, Vermeire S, Claessens G, Joossens S Vlietinck R, Rutgeerts P. Transmission of CARD15 (NOD2) variants within families of patients with inflammatory bowel disease. Am J Gastroenterol. 2004; 99(2): 299-305. PubMed | Google Scholar

  32. Zouiten-Mekki L, Zaouali H, Boubaker J, Karoui S, Fekih M, Matri S, Hamzaoui S, Filali A, Chaabouni H, Hugot JP. CARD15/NOD2 in a Tunisian population with Crohn's disease. Dig Dis Sci. 2005; 50(1): 130-5. PubMed | Google Scholar

  33. Leong RW, Armuzzi A, Ahmad T, Wong ML, Tse P, Jewell DP, Sung JJ. NOD2/CARD15 gene polymorphisms and Crohn's disease in the Chinese population. Aliment Pharmacol Ther. 2003; 17(12): 1465-70. PubMed | Google Scholar

  34. Yamazaki K, Takazoe M, Tanaka T, Kazumori T, Nakamura Y. Absence of mutation in the NOD2/CARD15 gene among 483 Japanese patients with Crohn's disease. J Hum Genet. 2002; 47(9): 469-72. PubMed | Google Scholar

  35. Ahmad T, Armuzzi A, Bunce M, Mulcahy-Hawes K, Marshall SE, Orchard TR Crawshaw J, Large O, de Silva A, Cook JT, Barnardo M, Cullen S, Welsh KI, Jewell DP. The molecular classification of the clinical manifestations of Crohn's disease. Gastroenterology. 2002; 122(4): 854-66. PubMed | Google Scholar

  36. Brant SR, PiccoMF, Achkar JP, Bayless TM, Kane SV, Brzezinski A, Nouvet FJ, Bonen D, Karban A, Dassopoulos T, Karaliukas R, Beaty TH, Hanauer SB, Duerr RH, Cho JH. Defining complex contributions of NOD2/CARD15 gene mutations, age at onset, and tobacco use on Crohn’s disease phenotypes. Inflamm Bowel Dis. 2003; 9(5): 281-9. PubMed | Google Scholar

  37. Mendoza JL, Murillo LS, Fernandez L, Pena AS, Lana R, Urcelay E, Cruz-Santamaría DM, de la Concha EG, Díaz-Rubio M, García-Paredes J. Prevalence of mutations of the NOD2/CARD15 gene and relation to phenotype in Spanish patients with Crohn disease. Scand J Gastroenterol. 2003; 38(12): 1235-40. PubMed | Google Scholar

  38. Radlmayr M, Torok HP, Martin K, Folwaczny C. The C-insertion mutation of the NOD2 gene is associated with fistulizing and fibrostenotic phenotypes in Crohn’s disease. Gastroenterology. 2002; 122(7): 2091-2. PubMed | Google Scholar

  39. Cuthbert AP, Fisher SA, Mirza MM, King K, Hampe J, Croucher PJ, Mascheretti S, Sanderson J, Forbes A, Mansfield J, Schreiber S, Lewis CM, Mathew CG. The contribution of NOD2 gene mutations to the risk and site of disease in inflammatory bowel disease. Gastroenterology. 2002; 122(4): 867-74. PubMed | Google Scholar

  40. Vavassori P, Borgiani P, D’Apice MR, De NF, Del Vecchio BG, Monteleone I, Biancone L, Novelli G, Pallone E. 3020insC mutation within the NOD2 gene in Crohn’s disease: frequency and association with clinical pattern in an Italian population. Dig Liver Dis. 2002; 34(2): 153. PubMed | Google Scholar

  41. Vermeire S, Wild G, Kocher K, Cousineau J, Dufresne L, Bitton A, Langelier D, Pare P, Lapointe G, Cohen A, Daly MJ, Rioux JD. CARD15 genetic variation in a Quebec population: prevalence, genotype-phenotype relationship, and haplotype structure. Am J Hum Genet. 2002; 71(1): 74-83. PubMed | Google Scholar

  42. Oostenbrug LE, Nolte IM, Oosterom E, Van der Steege G, Te Meerman GJ, Van Dullemen HM, Drenth JP, de Jong DJ, van der Linde K, Jansen PL, Kleibeuker JH. CARD15 in inflammatory bowel disease and Crohn’s disease phenotypes: An association study and pooled analysis. Dig Liver Dis. 2006; 38(11): 834-845. PubMed | Google Scholar

  43. Abreu MT, Taylor KD, Lin YC, Hang T, Gaiennie J, Landers CJ, Vasiliauskas EA, Kam LY, Rojany M, Papadakis KA, Rotter JI, Targan SR, Yang H. Mutations in NOD2 are associated with fibrostenosing disease in patients with Crohn’s disease. Gastroenterology. 2002; 123(3): 679-88. PubMed | Google Scholar